Magneto-sensitive liposomes containing manganese ferrite nanoparticles as nanocarriers for new promising antitumor thienopyridin-amine derivatives by Rodrigues, Ana Rita Oliveira et al.
Magneto-sensitive liposomes containing manganese ferrite nanoparticles as nanocarriers for 
new promising antitumor thienopyridin-amine derivatives 
 
Ana Rita O. Rodrigues,1 Ricardo C. Calhelha,2 Juliana M. Rodrigues,3 Isabel C.F.R. Ferreira,2 Maria 
João R. P. Queiroz,3 Paulo J. G. Coutinho,1 Elisabete M. S. Castanheira1 
 
1 Centre of Physics (CFUM), University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal 
2 Mountain Research Centre (CIMO), Polytechnic Institute of Bragança, 5301-855 Bragança, Portugal  
3 Centre of Chemistry (CQ-UM), University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal 
ritarodrigues@fisica.uminho.pt 
 
Magneto-sensitive liposomes, resulting from the encapsulation of magnetic nanoparticles into 
liposomes, combine the remarkable physical properties of these two types of systems, while preserving 
the magnetic properties of the nanoparticles. These nanosystems can overcome pharmacokinetics 
problems of the encapsulated drugs and can be guided and localized to the therapeutic sites of interest 
by external magnetic field gradients. The use of magneto-sensitive liposomes as nanocarriers allows a 
safer use of powerful anticancer drugs in therapy with lower drug dosage and a more efficient treatment. 
In this work, manganese ferrite (MnFe2O4) nanoparticles, with superparamagnetic behaviour at room 
temperature, were obtained by coprecipitation method and their structural and magnetic properties were 
evaluated [1]. The synthesized nanoparticles were either entrapped in liposomes, originating aqueous 
magnetoliposomes (AMLs), or covered with a lipid bilayer (solid magnetoliposomes, SMLs), with sizes 
below 150 nm (Figure 1), suitable for biomedical applications [1,2]. Membrane fusion between both 
types of magnetoliposomes and giant unilamellar vesicles, used as models of cell membranes, was 
confirmed by FRET (Förster Resonance Energy Transfer) assays [1,2]. 
New promising antitumor drugs, thienopyridine derivatives containing an amine moiety (compounds 1 
and 2, Figure 2) [3], were successfully incorporated in aqueous and solid magnetoliposomes, with 
encapsulation efficiencies between 75% and 89% for both antitumor compounds. Drug-loaded 
magnetoliposomes, containing compounds 1 or 2, presented very low growth inhibitory concentrations 
(GI50), between 0.09 and 5.67 µM, when tested in vitro against several human tumor cell lines; MCF-7 
(breast adenocarcinoma), NCI-H460 (non-small cell lung cancer), HeLa (cervical carcinoma) and T3M4 
(pancreatic cancer cells) [4]. These results are promising for future drug delivery applications using 
magnetoliposomes in oncology, allowing a dual therapeutic approach (simultaneous chemotherapy and 
magnetic hyperthermia). 
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Figure 1. TEM image of solid magnetoliposomes. 
 
 
 
  
  Figure 2. Structure of compounds 1 and 2.  
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